Alflorex Probiotic

Alflorex is a scientifically backed probiotic supplement developed by PrecisionBiotics. The brand's origin is rooted in over 20 years of research conducted at the APC Microbiome Institute at University College Cork (UCC) in Ireland. It is most famous for its unique 35624 strain of Bifidobacterium longum, which was specifically isolated to address digestive health and symptoms associated with Irritable Bowel Syndrome (IBS).

The brand was originally established by the Irish company PrecisionBiotics Group Ltd. In 2020, the company was acquired by the Danish health and nutrition giant Novozymes, which has since merged with Chr. Hansen to form Novonesis as of 2024. Today, Alflorex is manufactured primarily in Ireland, maintaining its heritage of clinical research and high-quality production standards for global distribution.